CD8A and neoplasm: Although HDACi can induce immunosuppressive effects, HDACi (TAA and VPA) increases the expression of NKG2D ligands (NKG2DL) on various tumor types [144,145], which triggers NK and CD8+ T cell cytolytic activity against tumors [144,145].